Antin Infrastructure Partners has acquired a majority stake in amedes Group from General Atlantic, positioning the diagnostic services leader for continued growth in the German and Belgian healthcare markets.
Information on the Target
The amedes Group is a leading provider of medical diagnostic services in Germany and Belgium, with a robust operational framework consisting of 35 laboratories and 27 practices across these nations. Specializing in interdisciplinary and medical-diagnostic services, amedes Group serves a diverse clientele that includes patients, medical practitioners, clinics, and other healthcare institutions. Each day, the organization processes over 150,000 laboratory samples utilizing state-of-the-art technology, underscoring its commitment to quality and efficiency in healthcare diagnostics.
With a dedicated workforce of approximately 3,500 employees, amedes boasts an impressive team that includes more than 365 doctors and technical assistants. This extensive resource base positions amedes as one of the foremost laboratory diagnostics companies within Germany, delivering trusted services that meet the growing demands of the healthcare sector.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Germany
The healthcare industry in Germany is distinguished by its increasing reliance on diagnostic services, essential for addressing the needs of an ageing population and the prevalence of chronic illnesses. As healthcare spending in Germ
Similar Deals
NORD Holding → Zentrum Gesundheit
2023
Antin Infrastructure Partners
invested in
amedes Holding AG
in 2023
in a Late-Stage VC deal